CNP vs STRO · P/E 26, rev $8.64B vs rev $62.0M
CenterPoint Energy Inc (CNP) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
CenterPoint Energy Inc (CNP) is a utilities - regulated electric company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CNP revenue for 2024-12-31 was $8.64B. Net income was $1.02B. Revenue was down 0.6% from 2023-12-31 to 2024-12-31. CNP currently screens at market cap $28.18B and trailing P/E 26.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CNP currently screens at market cap $28.18B and trailing P/E 26.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CNP and STRO stock pages for the full models.
Not investment advice.